Critical Path Public Private Partnerships Clinical Trials Optional

The Food and Drug Administration (FDA) is seeking an application to continue to maintain and manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative, which aims to develop innovative, collaborative projects in research, education, and outreach for fostering drug product innovation, enabling the acceleration of development, manufacturing, and translational therapeutics, enhancing safety, efficacy, quality, and performance. • The opportunity is for a cooperative agreement or grant to support the Critical Path Institute in its efforts to maintain and manage existing consortia groups. • The FDA will provide funding depending on availability, with an award ceiling and floor of $20,000,000. • The applicant eligibility is limited to the Critical Path Institute. • The funding instruments used will be a cooperative agreement or grant. • The funding activity categories include agriculture, consumer protection, and food and nutrition.